To elucidate the dual roles of IL-17 in tissue repair and identify regulatory determinants that influence its effects across different tissues, emphasizing its clinical significance.
Key Findings:
IL-17 has biphasic effects during tissue repair: it promotes repair in the acute phase and can lead to fibrosis in the chronic phase, with specific examples from recent studies.
The effects of IL-17 vary significantly across different tissues, including skin, lungs, and intestines, highlighting the need for tissue-specific approaches.
Key regulatory determinants include cellular origin, injury phase, signaling intensity, and local microenvironment, which should be detailed further.
Interpretation:
Understanding the conditions under which IL-17 promotes tissue repair versus exacerbates fibrosis is crucial for developing targeted therapeutic strategies, particularly in chronic inflammatory diseases.
Limitations:
Current evidence is largely organ-specific and fragmented, lacking a holistic perspective, particularly in the context of systemic diseases.
The review does not address all potential therapeutic implications or clinical applications, which should be acknowledged.
Conclusion:
A systematic understanding of IL-17's dual roles can inform the development of tailored therapeutic strategies for various clinical scenarios, particularly in autoimmune and chronic inflammatory conditions.
